Human S100A11 Antibody, R&D Systems™

S100A11

Monoclonal

LYOPH

Western Blot 2 ug/mL

P31949

S100A11

E. coli-derived recombinant human S100A11 Ala2-Thr105 Accession # P31949

100 μg

Primary

Detects human S100A11 in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human (rh) S100A1, A2, A4, A6, A7, A8, A9, A10, A13, rhS100B, rhS100P, recombinant mouse S100A1, A4, A6, A8, A9, A10, A11, A13, or A16 is observed.

Human

Purified

Western Blot

672816

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

calgizzarin, Metastatic lymph node gene 70 protein, MLN 70, MLN70, protein S100-A11, Protein S100-C, S100 calcium binding protein A11, S100 calcium-binding protein A11, S100 calcium-binding protein A11 (calgizzarin), S100C, S100CS100 calcium binding protein A11 (calgizzarin)

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

6282

Sterile PBS to a final concentration of 0.5 mg/mL.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG2b